Ryan Pewowaruk,Byron C Jaeger,Timothy M Hughes,Bharathi Upadhya,Dalane W Kitzman,Mark A Supiano,Adam D Gepner
{"title":"SPRINT患者血压控制对动脉硬化机制的影响:一项随机对照试验。","authors":"Ryan Pewowaruk,Byron C Jaeger,Timothy M Hughes,Bharathi Upadhya,Dalane W Kitzman,Mark A Supiano,Adam D Gepner","doi":"10.1161/hypertensionaha.124.24816","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nThe longitudinal impact of blood pressure (BP) control on the components of arterial stiffness has not been studied.\r\n\r\nMETHODS\r\nThe SPRINT (Systolic BP Intervention Trial) compared an intensive systolic BP goal (<120 mm Hg) to a standard goal (<140 mm Hg). Carotid-femoral pulse wave velocity (PWV) was measured in a subset of participants (n=605) at 0, 1, 2, and 3 years after randomization. Structural stiffening due to remodeling of the vessel wall and load-dependent stiffening, from changes in BP, were calculated by adjusting PWV to a 120/80 mm Hg reference BP with participant-specific models. The effect of intensive BP control on BP and arterial stiffness components over time was evaluated using generalized least squares regression.\r\n\r\nRESULTS\r\nIntensive BP control slowed the progression of PWV (total stiffness) compared with standard BP control at 3-year follow-up (-0.49 [-0.02 to -0.96] m/s, P=0.042). Differences in total stiffness between treatment groups over 3 years of follow-up were driven by intensive BP control reducing load-dependent PWV (-0.71 [-0.58 to -0.85] m/s, P<0.001), not structural PWV (+0.20 [-0.26 to +0.66], P=0.40). Load-dependent PWV was lower in the intensive treatment group at 1 year and remained lower throughout the follow-up. In contrast, structural PWV was similar between the 2 groups and increased throughout the follow-up period.\r\n\r\nCONCLUSIONS\r\nIntensive BP control slowed the progression of total arterial stiffness by decreasing load-dependent stiffness, but not through reduced structural stiffness. Future investigations are needed to determine if load-dependent PWV may have potential utility as a biomarker to monitor the efficacy of treatment and guide BP management strategies.\r\n\r\nREGISTRATION\r\nURL: https://www.clinicaltrials.gov; Unique identifier: NCT01206062.","PeriodicalId":13042,"journal":{"name":"Hypertension","volume":"35 1","pages":""},"PeriodicalIF":6.9000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of Blood Pressure Control on Arterial Stiffness Mechanisms in SPRINT: A Randomized Controlled Trial.\",\"authors\":\"Ryan Pewowaruk,Byron C Jaeger,Timothy M Hughes,Bharathi Upadhya,Dalane W Kitzman,Mark A Supiano,Adam D Gepner\",\"doi\":\"10.1161/hypertensionaha.124.24816\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND\\r\\nThe longitudinal impact of blood pressure (BP) control on the components of arterial stiffness has not been studied.\\r\\n\\r\\nMETHODS\\r\\nThe SPRINT (Systolic BP Intervention Trial) compared an intensive systolic BP goal (<120 mm Hg) to a standard goal (<140 mm Hg). Carotid-femoral pulse wave velocity (PWV) was measured in a subset of participants (n=605) at 0, 1, 2, and 3 years after randomization. Structural stiffening due to remodeling of the vessel wall and load-dependent stiffening, from changes in BP, were calculated by adjusting PWV to a 120/80 mm Hg reference BP with participant-specific models. The effect of intensive BP control on BP and arterial stiffness components over time was evaluated using generalized least squares regression.\\r\\n\\r\\nRESULTS\\r\\nIntensive BP control slowed the progression of PWV (total stiffness) compared with standard BP control at 3-year follow-up (-0.49 [-0.02 to -0.96] m/s, P=0.042). Differences in total stiffness between treatment groups over 3 years of follow-up were driven by intensive BP control reducing load-dependent PWV (-0.71 [-0.58 to -0.85] m/s, P<0.001), not structural PWV (+0.20 [-0.26 to +0.66], P=0.40). Load-dependent PWV was lower in the intensive treatment group at 1 year and remained lower throughout the follow-up. In contrast, structural PWV was similar between the 2 groups and increased throughout the follow-up period.\\r\\n\\r\\nCONCLUSIONS\\r\\nIntensive BP control slowed the progression of total arterial stiffness by decreasing load-dependent stiffness, but not through reduced structural stiffness. Future investigations are needed to determine if load-dependent PWV may have potential utility as a biomarker to monitor the efficacy of treatment and guide BP management strategies.\\r\\n\\r\\nREGISTRATION\\r\\nURL: https://www.clinicaltrials.gov; Unique identifier: NCT01206062.\",\"PeriodicalId\":13042,\"journal\":{\"name\":\"Hypertension\",\"volume\":\"35 1\",\"pages\":\"\"},\"PeriodicalIF\":6.9000,\"publicationDate\":\"2025-04-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hypertension\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1161/hypertensionaha.124.24816\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hypertension","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/hypertensionaha.124.24816","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
摘要
方法SPRINT(收缩压干预试验)比较了强化收缩压目标(<120 mm Hg)和标准目标(<140 mm Hg)。随机分组后的一部分参与者(605 人)在 0、1、2 和 3 年时测量了颈动脉-股动脉脉搏波速度 (PWV)。通过将脉搏波速度调整为 120/80 mm Hg 的参考血压,并使用参与者特定的模型计算出血管壁重塑导致的结构性僵化和血压变化导致的负荷依赖性僵化。结果与标准血压控制相比,强化血压控制减缓了脉搏波速度(总僵硬度)的进展,随访 3 年(-0.49 [-0.02 至 -0.96] m/s,P=0.042)。随访3年期间各治疗组之间总僵硬度的差异是由于强化血压控制降低了负荷依赖性脉搏波速度(-0.71 [-0.58 至 -0.85] m/s,P<0.001),而非结构性脉搏波速度(+0.20 [-0.26 至 +0.66],P=0.40)。强化治疗组在 1 年时负荷依赖性脉搏波速度较低,并在整个随访期间保持较低水平。结论强化血压控制可通过降低负荷依赖性僵硬度来减缓总动脉僵硬度的进展,但不能通过降低结构僵硬度来减缓总动脉僵硬度的进展。未来还需要进行研究,以确定负荷依赖性脉搏波速度是否有可能成为监测治疗效果和指导降压管理策略的生物标志物。注册网址:https://www.clinicaltrials.gov;唯一标识符:NCT01206062:NCT01206062。
Effects of Blood Pressure Control on Arterial Stiffness Mechanisms in SPRINT: A Randomized Controlled Trial.
BACKGROUND
The longitudinal impact of blood pressure (BP) control on the components of arterial stiffness has not been studied.
METHODS
The SPRINT (Systolic BP Intervention Trial) compared an intensive systolic BP goal (<120 mm Hg) to a standard goal (<140 mm Hg). Carotid-femoral pulse wave velocity (PWV) was measured in a subset of participants (n=605) at 0, 1, 2, and 3 years after randomization. Structural stiffening due to remodeling of the vessel wall and load-dependent stiffening, from changes in BP, were calculated by adjusting PWV to a 120/80 mm Hg reference BP with participant-specific models. The effect of intensive BP control on BP and arterial stiffness components over time was evaluated using generalized least squares regression.
RESULTS
Intensive BP control slowed the progression of PWV (total stiffness) compared with standard BP control at 3-year follow-up (-0.49 [-0.02 to -0.96] m/s, P=0.042). Differences in total stiffness between treatment groups over 3 years of follow-up were driven by intensive BP control reducing load-dependent PWV (-0.71 [-0.58 to -0.85] m/s, P<0.001), not structural PWV (+0.20 [-0.26 to +0.66], P=0.40). Load-dependent PWV was lower in the intensive treatment group at 1 year and remained lower throughout the follow-up. In contrast, structural PWV was similar between the 2 groups and increased throughout the follow-up period.
CONCLUSIONS
Intensive BP control slowed the progression of total arterial stiffness by decreasing load-dependent stiffness, but not through reduced structural stiffness. Future investigations are needed to determine if load-dependent PWV may have potential utility as a biomarker to monitor the efficacy of treatment and guide BP management strategies.
REGISTRATION
URL: https://www.clinicaltrials.gov; Unique identifier: NCT01206062.
期刊介绍:
Hypertension presents top-tier articles on high blood pressure in each monthly release. These articles delve into basic science, clinical treatment, and prevention of hypertension and associated cardiovascular, metabolic, and renal conditions. Renowned for their lasting significance, these papers contribute to advancing our understanding and management of hypertension-related issues.